A Randomized Evaluation of Vinorelbine Versus Gemcitabine Chemotherapy Mobilization of Stem Cells in Myeloma Patients
Barbara Jeker(University of Bern), Thomas Pabst(University Hospital of Bern), Ulrike Bacher(Hattiesburg Clinic), Urban Novak(University of Bern), Behrouz Mansouri Taleghani(University of Bern), Qiyu Li(Army Medical University), Sarah Farag(University of Bern)
Cited by 3
Related Papers
Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients
|Blood|2007|410
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
|Blood|2010|189
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
|Leukemia|2014|172